Vita 34 AG Stock
Price
Target price
€4.98
€4.98
10.300%
0.48
10.300%
-
28.03.24 / Tradegate
WKN: A0BL84 / Name: Vita 34 / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vita 34 AG Stock
Vita 34 AG dominated the market today, gaining €0.48 (10.300%).
So far the community has only identified positive things for Vita 34 AG stock. The most positive votes were given for criterium "Business model".
Pros and Cons of Vita 34 AG in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Vita 34 AG | 10.300% | 17.730% | 3.320% | -19.156% | -4.962% | -66.577% | -64.301% |
Mediclin AG | -3.910% | 6.897% | -3.125% | -22.013% | -6.767% | -43.119% | -54.074% |
M1 Kliniken AG | 2.360% | -3.321% | -1.504% | 111.974% | 18.018% | 15.929% | - |
Capital Senior Living Corp. | -10.140% | 7.258% | 150.943% | 193.923% | 207.514% | -15.287% | -49.042% |
News
EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023
EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023
EQS-News: Vita 34 downsizes Management Board until further notice
EQS-News: Vita 34 downsizes Management Board until further notice
EQS-Adhoc: Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors
EQS-Adhoc: Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors